Amlodipine / atorvastatin Alternatives Compared
| Amlodipine / atorvastatin | Repatha (evolocumab) | Leqvio (inclisiran) |
|
|---|
| Amlodipine / atorvastatin | Repatha (evolocumab) | Leqvio (inclisiran) |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for High Blood Pressure, High Cholesterol, Angina, Coronary Artery Disease, Prevention of Cardiovascular Disease. Amlodipine / atorvastatin may also be used for purposes not listed in this... View more |
Prescription only
Repatha is a PCSK9 inhibitor that may be used to reduce LDL-C levels in people with primary hyperlipidemia and HoFH, and also to reduce the risk of cardiovascular events in adults with established... View more |
Prescription only
Prescribed for High Cholesterol - Familial Heterozygous, High Cholesterol. Leqvio may also be used for purposes not listed in this medication guide. |
Related suggestions High Cholesterol
|
|||||||||||||||||||||||
| More about Amlodipine / atorvastatin | More about Repatha (evolocumab) | More about Leqvio (inclisiran) | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Amlodipine / atorvastatin has an average rating of 6.7 out of 10 from a total of 6 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 17% reported a negative effect. |
Repatha has an average rating of 5.2 out of 10 from a total of 680 ratings on Drugs.com. 39% of reviewers reported a positive effect, while 46% reported a negative effect. |
Leqvio has an average rating of 7.3 out of 10 from a total of 79 ratings on Drugs.com. 52% of reviewers reported a positive effect, while 5% reported a negative effect. |
||||||||||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Repatha side effects |
View all Leqvio side effects |
|||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
Lower cost generic |
N/A |
|||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Amlodipine / atorvastatin prices |
View all Repatha prices |
View all Leqvio prices |
||||||||||||||||||||||||
| Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Caduet |
N/A |
N/A |
||||||||||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
|
50 hours |
408 hours |
9 hours |
||||||||||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 747 drugs are known to interact with Amlodipine / atorvastatin:
|
A total of 2 drugs are known to interact with Repatha:
|
No known drug interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
|
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
January 30, 2004 |
August 27, 2015 |
N/A |
||||||||||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient Resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.